Open End-Turbo-Optionsschein auf .../ DE000HS6J075 /
2024-05-16 3:37:20 PM | Chg.- | Bid3:59:50 PM | Ask3:59:50 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.1100EUR | - | - Bid Size: 25,000 |
- Ask Size: 25,000 |
DERMAPHARM HLDG INH ... | 37.10 - | 2078-12-31 | Call |
GlobeNewswire
2:31 PM
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
2:30 PM
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
2:30 PM
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
2:30 PM
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
2:30 PM
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
2:30 PM
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
2:30 PM
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
2:30 PM
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
2:30 PM
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
2:20 PM
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
2:15 PM
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
2:14 PM
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
2:10 PM
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
2:07 PM
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
2:05 PM
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...